Turning Cancer’s instability against it
Beat Therapeutics is a biotechnology start-up, a spin-off from the University of Porto, dedicated to the discovery and development of innovative therapies in oncology. The company develops precision medicine approaches aimed at exploiting the biological vulnerabilities of tumors in order to improve the efficacy and safety of cancer treatments.
With a strong focus on translational research, Beat works on the development of new therapeutic candidates for aggressive cancers with limited therapeutic options, seeking to respond to unmet medical needs. Its mission is to contribute to significant advances in cancer treatment, with a real impact on patients’ survival and quality of life.
